Molecular Templates, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Common Share

Net Loss Per Common Share

9 Months Ended

Sep. 30, 2011

Net Loss Per Common Share [Abstract]

NOTE 2 — NET LOSS PER COMMON SHARE

Basic net loss per common share is computed by dividing net loss per share by the weighted-average number of vested common shares outstanding during the period. Diluted net loss per common share is computed by giving effect to all potential dilutive common shares, including outstanding options and warrants. A reconciliation of the numerator and denominator used in the calculation is as follows (in thousands, except per share amounts):


	Three Months Ended September 30,						Nine Months Ended September 30,
	2011			2010			2011			2010
Numerator:
Net loss	$	(4,125	)	$	(5,908	)	$	(20,378	)	$	(12,128	)

Denominator:
Weighted average common shares outstanding		49,052			33,672			44,812			33,638

Basic and diluted net loss per share	$	(0.08	)	$	(0.18	)	$	(0.45	)	$	(0.36	)

The following outstanding warrants, options and purchase rights under the Company's 2004 Employee Stock Purchase Plan were excluded from the computation of diluted net loss per share for the periods presented because including them would have had an antidilutive effect (in thousands):


	As of September 30,
	2011		2010
Shares issuable upon exercise of warrants		16,643		10,918
Shares issuable upon exercise of stock options		3,531		2,710
Shares issuable related to the ESPP		40		40